Referências Bibliográficas
1CENIE. Vinte e dois anos em branco: a diferença entre viver mais e viver bem. Available at: https://cenie.eu/pt/blog/vinte-e-dois-anos-em-branco-diferenca-entre-viver-mais-e-viver-bem. Accessed April 2026.
2Fernández-Ballesteros R, Valeriano-Lorenzo E, Sánchez-Izquierdo M, Botella J. Behavioral lifestyles and survival: a meta-analysis. Front Psychol. 2022 Feb 4;12:786491. doi: 10.3389/fpsyg.2021.786491
3MedlinePlus. Nutrition for older adults. National Library of Medicine, National Institutes of Health. Available at: https://medlineplus.gov/nutritionforolderadults.html. Accessed April 2026.
4Yeung SSY, Kwan M, Woo J. Healthy diet for healthy aging. Nutrients. 2021 Nov 29;13(12):4310. doi: 10.3390/nu13124310
5Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019 Feb 2;393(10170):434–445. doi: 10.1016/S0140-6736(18)31809-9
6Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013 Aug;14(8):542–559. doi: 10.1016/j.jamda.2013.05.021
7Schwingshackl L, Hoffmann G. Dietary fatty acids in the secondary prevention of coronary heart disease: a systematic review, meta-analysis and meta-regression. BMJ Open. 2014 Apr 19;4(4):e004487. doi: 10.1136/bmjopen-2013-004487
8World Health Organization. Healthy diet. Available at: https://www.who.int/news-room/fact-sheets/detail/healthy-diet. Accessed April 2026.
9World Health Organization. WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020. Available at: https://iris.who.int/server/api/core/bitstreams/9e776de6-adc7-46c1-936f-6dd2bb4f7373/content. Accessed April 2026.
10Ruivo JA, Alcântara P. Hypertension and exercise. Rev Port Cardiol. 2012;31(2):151-158. doi: 10.1016/j.repc.2011.12.012
11Fundação Portuguesa de Cardiologia. Alimentação e colesterol. Available at: https://www.fpcardiologia.pt/alimentacao-e-colesterol/. Accessed April 2026.
12Minihan A, Patel AV, Flanders WD, Sauer AG, Jemal A, Islami F. Proportion of cancer cases attributable to physical inactivity by US state, 2013–2016. Med Sci Sports Exerc. 2022 Mar;54(3):417–423. doi: 10.1249/MSS.0000000000002801
13Liga Portuguesa Contra o Cancro. Exercício físico e cancro: os benefícios durante e após a doença. Available at: https://www.ligacontracancro.pt/afdoentes/. Accessed April 2026.
14Meeusen R, De Meirleir K. Exercise and brain neurotransmission. Sports Med. 1995 Sep;20(3):160–188. doi: 10.2165/00007256-199520030-00004
15Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev. 2000 Jul;80(3):1055–1081. doi: 10.1152/physrev.2000.80.3.1055
16Centers for Disease Control and Prevention. Health benefits of physical activity for adults. Available at: https://www.cdc.gov/physical-activity-basics/about/index.html. Accessed April 2026.
17World Health Organization. Mental health of older adults. Available at: https://www.who.int/news-room/fact-sheets/detail/mental-health-of-older-adults. Accessed April 2026.
18Goodarzi F, Khoshravesh S, Ayubi E, Bashirian S, Barati M. Psychosocial determinants of functional independence among older adults: a systematic review and meta-analysis. Health Promot Perspect. 2024 Mar 14;14(1):32–43. doi: 10.34172/hpp.42354
19InformedHealth.org. How does the immune system work? National Library of Medicine, National Institutes of Health. Available at: https://www.ncbi.nlm.nih.gov/books/NBK279364/. Accessed April 2026.
20Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009 Nov;22(11):1041–1050. doi: 10.1111/j.1432-2277.2009.00927.x
21World Health Organization. Vaccines work at all ages, everywhere. Available at: https://www.who.int/news-room/commentaries/detail/vaccines-work-at-all-ages-everywhere. Accessed April 2026.
22World Health Organization. World Immunization Week 2016. Available at: https://www.who.int/news/item/21-04-2016-world-immunization-week-2016-immunization-game-changers-should-be-the-norm-worldwide. Accessed April 2026.
23Direção-Geral da Saúde. Programa Nacional de Vacinação: perguntas e respostas. Available at: https://www.dgs.pt/paginas-de-sistema/saude-de-a-a-z/programa-nacional-de-vacinacao/perguntas-e-respostas.aspx. Accessed April 2026.
24UK Health Security Agency. Shingles (herpes zoster): the green book, chapter 28a. Available at: https://www.gov.uk/government/publications/shingles-herpes-zoster-the-green-book-chapter-28a. Accessed April 2026.
25Helmuth IG, Poulsen A, Suppli CH, Mølbak K. Varicella in Europe — a review of the epidemiology and experience with vaccination. Vaccine. 2015 May 15;33(21):2406–2413. doi: 10.1016/j.vaccine.2015.03.055
26Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1–30.
27Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015 Jul;3(4):109–120. doi: 10.1177/2051013615599151
28Steinmann M, Lampe D, Grosser J, Schmidt J, Hohoff ML, Fischer A, et al. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns. Infection. 2024;52:1009–1026. doi: 10.1007/s15010-023-02156-y
29Giorda CB, Picariello R, Tartaglino B, Romeo F, Costa G, Gnavi R. Hospitalisation for herpes zoster in people with and without diabetes: a 10-year observational study. Diabetes Res Clin Pract. 2024 Apr;210:111603. doi: 10.1016/j.diabres.2024.111603
30Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017 Dec;92(12):1806–1821. doi: 10.1016/j.mayocp.2017.10.009
31Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009 Jan;137(1):38–47. doi: 10.1017/S0950268808000678
32National Institute for Health and Care Excellence (NICE). Shingles: complications. Clinical Knowledge Summaries. Available at: https://cks.nice.org.uk/topics/shingles/background-information/complications/. Accessed April 2026.
33National Health Service (NHS). Shingles. Available at: https://www.nhs.uk/conditions/shingles/. Accessed April 2026.
34Sociedade Portuguesa de Geriatria e Gerontologia (SPGG). Recomendações para a vacinação das pessoas idosas. Available at: http://spgg.com.pt/UserFiles/File/N0_Revista_SPGG.pdf. Accessed April 2026.
35Stephens LM, Varga SM. Understanding respiratory syncytial virus vaccine-enhanced disease. Vaccines (Basel). 2021 Jun 21;9(6):624. doi: 10.3390/vaccines9060624
36Tseng HF, Sy LS, Ackerson B, Solano Z, Slezak J, Luo Y, et al. Severe morbidity and short- and mid- to long-term mortality in older adults hospitalized with respiratory syncytial virus infection. J Infect Dis. 2020 Sep 14;222(8):1298–1310. doi: 10.1093/infdis/jiaa361
37Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019 Sep 18;366:l5021. doi: 10.1136/bmj.l5021
38Schweitzer JW, Justice NA. Respiratory syncytial virus infection (RSV). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459215/. Accessed April 2026.
39Centers for Disease Control and Prevention. RSV in older adults and adults with chronic medical conditions. Available at: https://www.cdc.gov/rsv/adults/index.html. Accessed April 2026.
40Bloom-Feshbach K, Alonso WJ, Charu V, Tamerius J, Simonsen L, Miller MA, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013;8(2):e54445. doi: 10.1371/journal.pone.0054445
41Centers for Disease Control and Prevention. RSV transmission. Available at: https://www.cdc.gov/rsv/about/transmission.html. Accessed April 2026.
42Belongia EA, King JP, Kieke BA, Pluta J, Al-Hilli A, Meece JK, et al. Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults ≥60 years old. Open Forum Infect Dis. 2018 Nov 27;5(12):ofy316. doi: 10.1093/ofid/ofy316
43Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, et al. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023 Feb 16;388(7):595–608. doi: 10.1056/NEJMoa2209604
44European Medicines Agency (EMA). First vaccine to protect older adults against respiratory syncytial virus (RSV) infection. Available at: https://www.ema.europa.eu/en/news/first-vaccine-protect-older-adults-respiratory-syncytial-virus-rsv-infection. Accessed April 2026.
45Mesa-Frias M, Rossi C, Emond B, Bookhart B, Anderson D, Drummond S, et al. Incidence and economic burden of respiratory syncytial virus among adults in the United States: a retrospective analysis using 2 insurance claims databases. J Manag Care Spec Pharm. 2022 Jul;28(7):753–765. doi: 10.18553/jmcp.2022.21459
46Centers for Disease Control and Prevention. Respiratory syncytial virus (RSV): information for healthcare providers. Available at: https://www.cdc.gov/rsv/index.html. Accessed April 2026.
47Blunck BN, Bhatt DL, Bhatt P, Thakkar S, Thai N, Osei-Hwedieh D, et al. Unmet medical needs in the treatment of influenza: a review. Vaccine. 2021 Feb 12;39(8):1248–1256. doi: 10.1016/j.vaccine.2021.01.010
48Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211048736. doi: 10.1177/1753466621995050
49National Institutes of Health (NIH). Talking with your doctor. Available at: https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/clear-communication/talking-your-doctor-or-health-care-provider. Accessed April 2026.
50SNS24. Difteria. Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/difteria/#sec-0. Accessed April 2026.
51Centers for Disease Control and Prevention. Diphtheria. Available at: https://www.cdc.gov/diphtheria/. Accessed April 2026.
52Direção-Geral da Saúde. Programa Nacional de Vacinação 2020. Available at: https://www.dgs.pt/ficheiros-de-upload-2013/pnv-esquema-recomendado-pdf11.aspx. Accessed April 2026.
53Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: pneumococcal disease. Available at: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-17-pneumococcal-disease.html. Accessed April 2026.
54World Health Organization. Pneumonia. Available at: https://www.who.int/news-room/fact-sheets/detail/pneumonia. Accessed April 2026.
55SNS24. Tosse convulsa (pertussis). Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/tosse-convulsa/. Accessed April 2026.
56Centers for Disease Control and Prevention. Pertussis (whooping cough): fast facts. Available at: https://www.cdc.gov/nchs/fastats/whooping-cough.htm. Accessed April 2026.
57Centers for Disease Control and Prevention. Pertussis (whooping cough): fast facts. Available at: https://www.cdc.gov/pertussis/about/index.html. Accessed April 2026.
58Centers for Disease Control and Prevention. Pertussis (whooping cough): prevention. Available at: https://www.cdc.gov/pertussis/about/prevention/index.html. Accessed April 2026.
59SNS24. Tétano. Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/tetano/. Accessed April 2026.
60Centers for Disease Control and Prevention. Tetanus: symptoms and complications. Available at: https://www.cdc.gov/tetanus/about/index.html. Accessed April 2026.
61Centers for Disease Control and Prevention. Tetanus: diagnosis and treatment. Available at: https://www.cdc.gov/tetanus/causes/index.html. Accessed April 2026.
62Centers for Disease Control and Prevention. Meningococcal disease. Available at: https://www.cdc.gov/meningococcal/index.html. Accessed April 2026.
63World Health Organization. Meningococcal meningitis. Available at: https://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis. Accessed April 2026.
64Centers for Disease Control and Prevention. Meningococcal disease: diagnosis, treatment, and complications. Available at: https://www.cdc.gov/meningococcal/about/diagnosis-treatment.html. Accessed April 2026.
65SNS24. Meningite meningocócica. Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/meningite-bacteriana/. Accessed April 2026.
66Meningitis Research Foundation. Are you at risk? Available at: https://www.meningitis.org/about-meningitis/am-i-at-risk-from-meningitis/. Accessed April 2026.
67Centers for Disease Control and Prevention. Meningococcal disease: risk factors. Available at: https://www.cdc.gov/meningococcal/about/risk-factors.html. Accessed April 2026.
68Meningitis Research Foundation. After effects of meningitis and septicaemia. Available at: https://www.meningitis.org/meningitis/after-effects. Accessed April 2026.
69Viner RM, Coffey C, Mathers C, Bloem P, Costello A, Santelli J, et al. 50-year mortality trends in children and young people: a study of 50 low-income, middle-income, and high-income countries. Lancet. 2011 Apr 2;377(9772):1162–1174. doi: 10.1016/S0140-6736(11)60106-2
70Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, et al. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015 Mar 1;60(8):e27–e35. doi: 10.1093/cid/ciu1016
71Meningitis Research Foundation. Symptoms of meningitis and septicaemia. Available at: https://www.meningitis.org/meningitis/check-symptoms/. Accessed April 2026.
72Centers for Disease Control and Prevention. Haemophilus influenzae disease (including Hib). Available at: https://www.cdc.gov/hi-disease/about/index.html. Accessed April 2026.
73European Centre for Disease Prevention and Control (ECDC). Invasive Haemophilus influenzae disease. Available at: https://www.ecdc.europa.eu/en/invasive-haemophilus-influenzae-disease/facts. Accessed April 2026.
74Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: rotavirus. Available at: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-19-rotavirus.html. Accessed April 2026.
75Centers for Disease Control and Prevention. Rotavirus: symptoms. Available at: https://www.cdc.gov/rotavirus/about/index.html. Accessed April 2026.
76Sociedade de Infecciologia Pediátrica / Sociedade Portuguesa de Pediatria (SIP-SPP). Vacinas extra-PNV: recomendações 2020. Available at: https://www.docdroid.com/YQZZXg7/sip-recomendacoesvacinas-pdf. Accessed April 2026.
77SNS24. Hepatite A. Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/virus-da-hepatite-a-vha/#sec-0. Accessed April 2026.
78World Health Organization. Hepatitis A. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-a. Accessed April 2026.
79Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases: hepatitis A. Available at: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-9-hepatitis-a.html. Accessed April 2026.
80SNS24. Hepatite B. Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/vhb/. Accessed April 2026.
81World Health Organization. Hepatitis B. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed April 2026.
82SNS24. Papeira (parotidite). Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/papeira-ou-parotidite/. Accessed April 2026.
83European Centre for Disease Prevention and Control (ECDC). Mumps. Available at: https://www.ecdc.europa.eu/en/mumps/facts. Accessed April 2026.
84National Health Service (NHS). Mumps. Available at: https://www.nhs.uk/conditions/mumps/. Accessed April 2026.
85SNS24. Poliomielite. Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/poliomielite/. Accessed April 2026.
86World Health Organization. Poliomyelitis (polio). Available at: https://www.who.int/news-room/fact-sheets/detail/poliomyelitis. Accessed April 2026.
87SNS24. Rubéola. Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/rubeola/. Accessed April 2026.
88Centers for Disease Control and Prevention. Rubella: complications. Available at: https://www.cdc.gov/rubella/signs-symptoms/index.html. Accessed April 2026.
89SNS24. Sarampo. Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/sarampo/. Accessed April 2026.
90World Health Organization. Measles. Available at: https://www.who.int/news-room/fact-sheets/detail/measles. Accessed April 2026.
91National Health Service (NHS). Measles. Available at: https://www.nhs.uk/conditions/measles/. Accessed April 2026.
92SNS24. Varicela. Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/varicela/. Accessed April 2026.
93Centers for Disease Control and Prevention. Chickenpox (varicella): clinical overview. Available at: https://www.cdc.gov/chickenpox/hcp/clinical-overview/index.html. Accessed April 2026.
94SNS24. COVID-19. Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/covid-19/. Accessed April 2026.
95World Health Organization. Coronavirus disease (COVID-19): Q&A. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub. Accessed April 2026.
96SNS24. Vírus do papiloma humano (HPV). Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/virus-do-papiloma-humano-hpv/#sec-0. Accessed April 2026.
97Liga Portuguesa Contra o Cancro / HPV.pt. O que é o HPV? Available at: https://www.hpv.pt/o-que-e-o-hpv/. Accessed April 2026.
98World Health Organization. Human papillomavirus vaccines: WHO position paper. Available at: https://cdn.who.int/media/docs/default-source/immunization/position_paper_documents/human-papillomavirus-(hpv)/hpv-choice-recommendation-table.pdf. Accessed April 2026.
99SNS24. Febre amarela. Available at: https://www.sns24.gov.pt/tema/doencas-infecciosas/febre-amarela/. Accessed April 2026.
100Centers for Disease Control and Prevention. Yellow fever. Available at: https://www.cdc.gov/yellow-fever/index.html. Accessed April 2026.
101Australian Government Department of Health and Aged Care. Australian Immunisation Handbook: yellow fever. Available at: https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/yellow-fever. Accessed April 2026.
102SNS24. Febre tifoide. Available at: https://www.sns24.gov.pt/pt/tema/doencas/doencas-infecciosas/febre-tifoide/. Accessed April 2026.
103World Health Organization. Typhoid. Available at: https://www.who.int/news-room/fact-sheets/detail/typhoid. Accessed April 2026.
104National Health Service (NHS). Typhoid fever: complications. Available at: https://www.nhs.uk/conditions/typhoid-fever/complications/. Accessed April 2026.
105National Health Service (NHS). Typhoid fever: treatment. Available at: https://www.nhs.uk/conditions/typhoid-fever/treatment/. Accessed April 2026.
106Silva F, Castro Castanheira R, Zarkadoulas E, Figueira D, Bulhosa C, Borges M, et al. Landscape of herpes zoster infections in Portugal — incidence in Portugal. Apresentado no: Encontro de Outono da APMGF; 2024.